2022
DOI: 10.3390/bios12040255
|View full text |Cite
|
Sign up to set email alerts
|

Application of Self-Assembly Nanoparticles Based on DVDMS for Fenton-Like Ion Delivery and Enhanced Sonodynamic Therapy

Abstract: Upon harnessing low-intensity ultrasound to activate sonosensitizers, sonodynamic therapy (SDT) induces cancer cell death through the reactive oxygen species (ROS) mediated pathway. Compared with photodynamic therapy (PDT), SDT possesses numerous advantages, including deeper tissue penetration, higher accuracy, fewer side effects, and better patient compliance. Sinoporphyrin sodium (DVDMS), a sonosensitizer approved by the FDA, has drawn abundant attention in clinical research, but there are some deficiencies.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…When back to the low energy status, a large amount of energy is released, that stimulates hematoporphyrin to produce extremely unstable trivalent hematoporphyrin which quickly splits into monovalent hematoporphyrin, releasing O-based ROS. SDT uses ultrasound to have a strong ability to penetrate biological tissues [237][238][239]. In particular, focused ultrasound can non-invasively focus sound energy on deep tissues to activate some sound-sensitive catalysts to finally trigger the formation of ROS, which provides a potential localization treatment method to reduce the risk of side effects in other parts of the body.…”
Section: Other Trigger Pathway Catalystsmentioning
confidence: 99%
“…When back to the low energy status, a large amount of energy is released, that stimulates hematoporphyrin to produce extremely unstable trivalent hematoporphyrin which quickly splits into monovalent hematoporphyrin, releasing O-based ROS. SDT uses ultrasound to have a strong ability to penetrate biological tissues [237][238][239]. In particular, focused ultrasound can non-invasively focus sound energy on deep tissues to activate some sound-sensitive catalysts to finally trigger the formation of ROS, which provides a potential localization treatment method to reduce the risk of side effects in other parts of the body.…”
Section: Other Trigger Pathway Catalystsmentioning
confidence: 99%
“…When CDT is combined with SDT, enhancing the efficiency of ROS generation and promoting the diffusion of nanoparticles to the deep sites of the tumor can significantly improve the therapeutic effect on the tumor. 129 Therefore, it is important to develop nanomaterials with high tumor specificity that bind CDT and SDT and modulate the tumor microenvironment.…”
Section: Sonodynamic Therapy-based Combination Therapymentioning
confidence: 99%
“…[37,38] The process of SDT treatment will also induce certain changes in the immune environment, leading to long-term systemic antitumor immunity. However, the weak acidity of the Reverse immunosuppression CS-ID@NMS [49] Consumption of GSH Cu/DVDMS [149] Reverse immunosuppression, Consumption of GSH NPMCA [150] Relieve hypoxia Pd/H-TiO 2 NSs [151] TME-response Arg@VMT@PDA-PEG NSs [152] Catalytic conversion of H 2 O 2 to CO 2…”
Section: Introductionmentioning
confidence: 99%